2Kannel WB,Belanger AJ.Epidemiology of heart failure.Am Heart J,1991,121:951-957. 被引量：1
3Jernberg T,Stridsberg,M,Venge P,et al.N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.J Am Coll Cardiol,2002,40:437-445. 被引量：1
4Troughton RW,Frampton CM,Yandle TG,et al.Treament of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP)concentrations.Lancet,2000,355:1126-1130. 被引量：1
6Selvais PI., Donekier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary atery disease oncardiac hormonal activation. Eur Jain Invest,2008, 28,636-642. 被引量：1
7Ferraro S, Marddalena G, Fazio S, et al. Acute and short-term efficacy of hish doses of ereatine phosphate in the treatment of eardial failure. Cur ther Res, 1990,47 :917-923. 被引量：1
8Fragasso G, Perseghin G, Cobelli DF, et al, Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine /adenosine triphosphate ratio in patients with heart failure . Eur Heart J,2006,27:942-948. 被引量：1
9Suzuki S, Yoshimura M, Nakayama M, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infrarction:a long-term follow-up analysis. G rculation, 2004,110 : 1387-1391. 被引量：1
